tirzepatide did not work for me shows greater average weight loss than semaglutide., 15% vs 20–22% on paper., But weight loss numbers don’t tell the whole story., How much was fat vs muscle?, How patients feel long Why Am I Not Losing

In the SURMOUNT-1 trial in people with obesity or overweight with weight-related complications, 72-week tirzepatide treatment led to clinically meaningful body weight and blood pressure reduction

During the time of your treatment, we require monthly visits for the first 4 months

As the dialogue on obesity treatment solidifies its place on global health agendas, the future of pharmacotherapies like tirzepatide looks promising, buoyed by research like this that underscores their potential to create lasting change in patients health outcomes

Get storage right and the color stays consistent

WykoffCCDoDVGoldbergRADhootDSLimJIDuWet al

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice